Back to Search Start Over

The impact of histopathologic examination of graft-versus-host disease in the era of reduced-intensity conditioning regimen: a study from the Gruppo Italiano Trapianto di Midollo Osseo

Authors :
Fedro A. Peccatori
Loredana Villari
Paola Rafaniello
Marco Casini
Francesca Patriarca
Silvia Benemei
Luca Messerini
Roberto Raimondi
Anna Maria Cesinaro
Maurilio Ponzoni
Francesco Lapi
Giovanni Negri
Chiara Nozzoli
Vito Colombetti
Andrea Tendas
Edvige Salomone
Camilla E. Comin
Giuseppe Milone
Luca Albarello
Amedea Donelli
Stefano Guidi
Marco Santucci
Fabio Ciceri
Emanuela Bonoldi
Cristina Fondi
Davide Rapezzi
Daniela Massi
Alberto Bosi
Claudio Avellini
Stefano Fratoni
Mirella Fortunato
Massi, D
Fondi, C
Nozzoli, C
Benemei, S
Lapi, F
Albarello, L
Avellini, C
Bonoldi, E
Casini, M
Cesinaro, Am
Ciceri, Fabio
Colombetti, V
Comin, Ce
Donelli, A
Fortunato, M
Fratoni, S
Guidi, S
Messerini, L
Milone, G
Rapezzi, D
Negri, G
Patriarca, F
Peccatori, Fa
Ponzoni, Maurilio
Rafaniello, P
Raimondi, R
Salomone, E
Tendas, A
Villari, L
Santucci, M
Bosi, A.
Source :
Human pathology. 42(2)
Publication Year :
2010

Abstract

Reduced-intensity conditioning regimens have reshaped the clinical presentation of graft-versus-host disease after hematopoietic stem cell transplants. However, histopathologic features of graft-versus-host disease following reduced-intensity conditioning regimens have not been fully characterized. In a series of 112 biopsies (skin, n = 60; gastrointestinal [GI] tract, n = 44; liver, n = 8), we described the morphologic profile of graft-versus-host disease following reduced-intensity conditioning and investigated whether histopathologic changes of graft-versus-host disease following reduced-intensity conditioning have a diagnostic and/or prognostic value. Forty-four patients (49.5%) experienced acute graft-versus-host disease, 2(2.2%) late-onset acute graft-versus-host disease (grade I, n = 13; grade II-IV, n = 33), 24(27.0%) chronic graft-versus-host disease (de novo n = 12, progressive n = 12) and 19 (21.3%) overlap syndrome. In the skin, we observed: (i) phase-nonspecific changes, such as acute graft-versus-host disease features in chronic graft-versus-host disease patients (n = 4/24; 16.6%), (ii) subtle alterations such as superficial fibrosis in widened dermal papillae (n = 8), in acute graft-versus-host disease/late-onset graft-versus-host disease (n = 6/46; 13.0%) or chronic graft-versus-host disease (n = 2/24, 8.3%) patients, and (iii) features of chronic and acute graft-versus-host disease coexisting in the same specimen in overlap syndrome (n = 3/19; 15.7%). In the GI tract, we did not demonstrate peculiar features differing from those commonly observed in the myeloablative setting. By univariate analysis, a reduced overall survival was associated with graft-versus-host disease type (chronic graft-versus-host disease P = .006, acute graft-versus-host disease P = .03), older age (P = .04), and histopathologic diagnosis of "consistent with" + definite graft-versus-host disease (P = .02). Histopathologic diagnosis retained an independent prognostic value by multivariate analysis (P = .01). The present study indicates that pathologists should be aware of the peculiar morphologic changes of cutaneous graft-versus-host disease following reduced-intensity conditioning and further recommends histopathology in the diagnostic workup of graft-versus-host disease in patients undergoing reduced-intensity conditioning regimen. (C) 2011 Elsevier Inc. All rights reserved.

Details

ISSN :
15328392
Volume :
42
Issue :
2
Database :
OpenAIRE
Journal :
Human pathology
Accession number :
edsair.doi.dedup.....15d8a3825722ce5e0ebd9c5054def151